DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Nifurquinazol
Nifurquinazol
Un Novedoso Enfoque Para El Diseño De Fármacos Antimicrobianos Asistido Por Computadora
The Organic Chemistry of Drug Synthesis
Anew Drug Design Strategy in the Liht of Molecular Hybridization Concept
Pharmaceutical Appendix to the Tariff Schedule 2
(12) United States Patent (10) Patent No.: US 8,993,540 B2 Haggard Et Al
Marrakesh Agreement Establishing the World Trade Organization
Customs Tariff - Schedule
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(12) United States Patent (10) Patent No.: US 9,072,728 B2 Rufo Et Al
Stembook 2018.Pdf
WO 2016/066256 Al 6 May 2016 (06.05.2016) W P O P C T
Compositions, Methods and Devices for Generating Nanotubes on a Surface
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
The Two Tondition Multituduhan
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
WO 2009/059191 Al
Customs Tariff - Schedule
Top View
(12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
Wo 2007/044693 A2
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
9504742.Pdf (2.885Mb)
Customs Tariff - Schedule
(12) United States Patent (10) Patent No.: US 8,232,265 B2 Rogers Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Annex Ii-2 Agreement Establishing The
Harmonized Tariff Schedule of the United States (2006) (Rev
Q06004.Pdf (2.756Mb)
1111111111111111111Imnumu
(12) United States Patent (10) Patent No.: US 9.243,037 B2 Gao Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Rpt POL-TOXIC AIR POLLUTANTS 98 by ALPHA